BOCA RATON, Fla., Sept. 14, 2004 (PRIMEZONE) -- Pure H20 Bio-Technologies, Inc. (Pink Sheets:PHBT) announced today the appointment of George Weast to serve in the capacity as Chief Financial Officer, who will report directly to the Board of Directors of the Company.
"We are pleased that Mr. Weast has agreed to join the Company to fill this position as CFO. He is the ideal candidate to lead PHBT to the next level," said Joseph P. Doxey, President of PHBT. "Mr. Weast will direct the coordination of PHBT's audited financial statements. Upon completion of these audits, PHBT will immediately file Form 10SB with the Securities and Exchange Commission to effect a reporting status."
Mr. Weast, a graduate of the University of Maryland, is a former director of two national banks and has over 30 years of accounting and financial business experience. He served as CFO for a publicly traded information retrieval company and also served as president and founder of Weston Leasing Company, also publicly traded. Additionally, Mr. Weast served as President and founder of American Investors, Inc., in the Washington D.C. metropolitan area, and Washington Capital Corporation where he combined his skills as a consultant to banks, investment banking firms and professional money managers.
PHBT is a publicly held company specializing in the manufacturing, design and sale of its unique residential, commercial and hospital point-of-use potable water disinfection systems. These systems are specifically designed to work effectively against water-borne pathogens and remove heavy metals and objectionable biomass.
Note: The foregoing press release contains forward-looking statements that can be identified by such terminology as "expects," "potential," "suggests," "may," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed of implied by such statements. In particular, management's expectations regarding future research, development, and/or commercial results could be affected by, among other things, uncertainties relating to the availability of future financing; unexpected regulatory delays or government regulation generally; the company's ability to obtain or maintain patent and other proprietary intellectual property protection; and completion in general. Forward-looking statements speak only as to the date they were made. The company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
For further information regarding PHBT, please visit our website @ www.pureh2obiotech.com